Sphera Funds Management Ltd. Galmed Pharmaceuticals Ltd. Transaction History

Sphera Funds Management Ltd.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2018 May 10, 2018	SELL	$5.12 - $11.77 $1.22 Million - $2.8 Million	-238,095 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$6.78 - $9.32 $1.61 Million - $2.22 Million	238,095	238,095 $2.16 Million

Ticker GLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,088,400
Market Cap $77.8M
Description
Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or t...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.